-
Fatemeh Sadat Heidari Rahmatabadi
ORCID:
- Researcher ID:
- Scopus:
- Google Scholar:
- Research Gate:
SCIENTIFIC CAREER
Since 2024
PhD Candidate C-MYC, Faculty of Medicine, University of Bergen, Norway
2022 – 2024 Master Student at Master in Biomedical Sciences, Faculty of Medicine, University of Bergen, Norway
2017 – 2021 Bachelor of Science in Cell and Molecular Biology, Islamic Azad University of Mashhad, Mashhad, Iran
POSTER presentations
- Fatemeh Sadat Heidari Rahmatabadi, Tuyen Hoang, Vibeke Andresen, Gro Gausdal, Simona Chera, Bjørn Tore Gjertsen, Luiza Ghila. Targeting MAPK/ERK Signaling Pathway to Overcome Chemotherapy Resistance in Acute Myeloid Leukemia, CCBIO’s 13th Annual Symposium, 13-14 May 2025, Solstrand, Norway
Journal Club Posts
- RSK1 dependency in FLT3-ITD acute myeloid leukemia
- Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models
- ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease
- The p38 pathway inhibitor, SB202190, activates MEK/MAPK to stimulate the growth of leukemia cells